维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

4篇 您的检索式：作者名="Catherine AI"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Theintraportalinjection mod- elforliver metastasis:advantages of associated bioluminescence to assess tumorgrowth andinfluences on tumoruptake of radiola-beled anti-carcinoembryonic antigen antibody显示文摘	Eric F Catherine M Philippe T et aI	2011	Nuclear Me- dicine Communications2011，32，2：	1
	2	The epiderniology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi显示文摘	Catherine AI Jo- Anne R John WT	1998	Lancet1998，351，：	1
	3	Radiological Eeasoning:Bone Marrow Changes on ME显示文摘	Paul G Swartz Catherine C et aI	2009	AJR2009，93，3：	1
	4	De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation显示文摘Metabolic dysfunction-associated fatty liver disease(MAFLD)is a new acronym adopted from the consensus of international experts.Given the increasing prevalence of MAFLD in pre-transplant settings,de novo and recurrent graft steatosis/MAFLD are common in post-transplant settings.The impact of graft steatosis on long-term outcomes is unclear.The current knowledge of incidence rate,risk factors,diagnosis,long-term outcomes,and management of graft steatosis(both de novo and recurrent)is discussed in this review.	Ma Ai Thanda Han Raquel Olivo Catherine J Choi Nikolaos Pyrsopoulos	2021	World Journal of Hepatology2021，13，12：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费